Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate
NCT ID: NCT03374306
Last Updated: 2024-10-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
71 participants
INTERVENTIONAL
2018-02-01
2020-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low-dose Atropine for Myopia Control in Children
NCT03865160
Low-Dose Atropine for Treatment of Myopia
NCT03334253
Topical 0.01% Atropine for the Control of Fast Progressing Myopia
NCT04173780
The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression
NCT06708156
Combined Atropine With Orthokeratology in Childhood Myopia Control (AOK) -A Randomized Controlled Trial
NCT02955927
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Atropine 0.01%
Group receiving atropine treatment for 18 months
Atropine (0.01%)
tropical application
Artifical tear
Group receiving placebo for 18 months
Artificial tear
tropical application
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Atropine (0.01%)
tropical application
Artificial tear
tropical application
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good general health and no family history of ocular diseases
* No current or history of epilepsy or asthma
* Myopia : -0.50 to -1.00 D (inclusive, both eyes)
* Astigmatism : ≤ 0.50 D
* No hyperopia, amblyopia or strabismus
* No reported ocular eye diseases or disorders
* No drug allergy
7 Years
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Hong Kong
OTHER
The Hong Kong Polytechnic University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Henry HL Chan, PhD
Association Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henry HL CHAN, PhD
Role: PRINCIPAL_INVESTIGATOR
The Hong Kong Polytechnic University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
School of Optometry, Hong Kong Polytechnic University
Hong Kong, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HongKongPU_Optometry1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.